ATE232210T1 - Verfahren zur herstellung von erythromicin a-oxim - Google Patents

Verfahren zur herstellung von erythromicin a-oxim

Info

Publication number
ATE232210T1
ATE232210T1 AT97907949T AT97907949T ATE232210T1 AT E232210 T1 ATE232210 T1 AT E232210T1 AT 97907949 T AT97907949 T AT 97907949T AT 97907949 T AT97907949 T AT 97907949T AT E232210 T1 ATE232210 T1 AT E232210T1
Authority
AT
Austria
Prior art keywords
oxime
erythromicin
producing
erythromycin
isopropanol
Prior art date
Application number
AT97907949T
Other languages
English (en)
Inventor
Sou-Jen Chang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24526649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE232210(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE232210T1 publication Critical patent/ATE232210T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
AT97907949T 1996-04-10 1997-02-27 Verfahren zur herstellung von erythromicin a-oxim ATE232210T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/630,306 US5808017A (en) 1996-04-10 1996-04-10 Process for preparing erythromycin A oxime
PCT/US1997/003177 WO1997038000A1 (en) 1996-04-10 1997-02-27 Process for preparing erythromycin a oxime

Publications (1)

Publication Number Publication Date
ATE232210T1 true ATE232210T1 (de) 2003-02-15

Family

ID=24526649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907949T ATE232210T1 (de) 1996-04-10 1997-02-27 Verfahren zur herstellung von erythromicin a-oxim

Country Status (8)

Country Link
US (1) US5808017A (de)
EP (1) EP0970099B1 (de)
JP (1) JP4004068B2 (de)
AT (1) ATE232210T1 (de)
DE (1) DE69718942T2 (de)
DK (1) DK0970099T3 (de)
ES (1) ES2191821T3 (de)
WO (1) WO1997038000A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6504017B1 (en) * 1997-07-08 2003-01-07 Biochemie S.A. Erthromycin a oxime solvates
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
IN190782B (de) * 1998-09-30 2003-08-23 Max India Ltd
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
CN1666991A (zh) * 1999-12-16 2005-09-14 特瓦制药工业有限公司 克拉霉素多晶型物的制备方法和新的多晶型物ⅳ
FR2802534B1 (fr) * 1999-12-20 2002-02-01 Merial Sas Procede pour preparer et isoler la 9-deoxo-9 (z)- hydroxyiminoerythromycine a
US6590084B2 (en) 1999-12-20 2003-07-08 Merial Process for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
DK1280535T3 (da) * 2000-01-11 2005-04-04 Teva Pharma Processer til fremstilling af clarithromycin polymorfer
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
EP1313486A1 (de) 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung des clarithromycins und eines clarithromycin-zwischenprodukt; clarithromycin wesentlich frei von oxime; und pharmazeutische zusammensetzung die sie enthalten
CA2403757A1 (en) * 2000-03-28 2001-10-04 Biochemie Gesellschaft M.B.H. Granulated particles with masked taste
WO2002015842A2 (en) * 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
IL161800A0 (en) * 2001-11-07 2005-11-20 Aventis Pharma Gmbh Method for the production of desclarithromycin, and intermediateproducts
EP1648407A4 (de) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
CN101362783B (zh) * 2008-10-06 2011-12-07 浙江国邦药业有限公司 一种红霉素a(e)肟的制备方法
CN102911225A (zh) * 2011-08-04 2013-02-06 山东方明药业集团股份有限公司 红霉素a肟的清洁化合成方法及其特别组合的反应设备
CN103897002A (zh) * 2012-12-31 2014-07-02 菏泽市方明制药有限公司 一种粗品硫氰酸红霉素制备红霉素a9-肟的方法
CN103923142B (zh) * 2014-04-30 2017-01-11 浙江震元制药有限公司 一种罗红霉素中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法

Also Published As

Publication number Publication date
DE69718942T2 (de) 2003-12-11
DE69718942D1 (de) 2003-03-13
DK0970099T3 (da) 2003-05-26
JP4004068B2 (ja) 2007-11-07
EP0970099A1 (de) 2000-01-12
WO1997038000A1 (en) 1997-10-16
ES2191821T3 (es) 2003-09-16
JP2000508311A (ja) 2000-07-04
US5808017A (en) 1998-09-15
EP0970099B1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
DE69718942D1 (de) Verfahren zur herstellung von erythromicin a-oxim
DE69716767D1 (de) Verfahren zur herstellung von tolterodin
DE59709121D1 (de) Verfahren zur herstellung von wasserstoffperoxid
ATE321017T1 (de) Verfahren zur herstellung von 3,3-dimethylbutanal
ATE271070T1 (de) Verfahren zur herstellung eines metallocen- katalysatorsystems
DE69526436D1 (de) Verfahren zur herstellung von avermectin/zein-zusammensetzungen
DE3761983D1 (de) Verfahren zur herstellung von farbstarken, im nitrobenzolreduktionsverfahren erhaltenen eisenoxidschwarzpigmente.
ATE117994T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethylpyridin.
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
ATE199247T1 (de) Verfahren zur herstellung von 1-aryl-1- cyanocyclobutan-derivaten
DE69808771T2 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE207880T1 (de) Verfahren zur herstellung von kontrastmitteln
DE60108879D1 (de) Verfahren zur herstellung von seltenen carotinoiden ausgehend von handelsüblichem lutein
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE69010256T2 (de) Verfahren zur Herstellung von L-Ornithin durch Fermentation.
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE59801963D1 (de) Verfahren zur herstellung von celluloseacetat
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
DE68916022D1 (de) Verfahren zur herstellung von wasserstoffgas.
ATE248807T1 (de) Verfahren zur herstellung von n-hydrocarbyl- substituierten amiden
ATA732379A (de) Verfahren zur herstellung von 1alpha, 3betadihydroxy-delta5-steroiden
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE69803539D1 (de) Verfahren zur Herstellung von 4-Sulfonamidopenylhydrazinen
DE69709750D1 (de) Verfahren zur herstellung von 4,4,4-trichlorbutanol
ATE121731T1 (de) Verfahren zur herstellung von irone.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0970099

Country of ref document: EP

REN Ceased due to non-payment of the annual fee